Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma.

Benjamin, David J; Mar, Nataliya; Rezazadeh Kalebasty, Arash

Benjamin, David J; Mar, Nataliya; Rezazadeh Kalebasty, Arash.

Afiliação

Benjamin DJ; Medical Oncology, Hoag Family Cancer Institute, Newport Beach, CA, USA.
Mar N; Division of Hematology and Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, USA.
Rezazadeh Kalebasty A; Division of Hematology and Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, USA.

Clin Med Insights Oncol ; 16: 11795549221126252, 2022.

Article em En | MEDLINE | ID: mdl-36186672

Palavras-chave

FGFR; Urothelial carcinoma; bladder cancer; checkpoint inhibitor; erdafitinib; immunotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Med Insights Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google